Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) > Morpholines (i.e., fully hydrogenated 1,4- oxazines) > Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding > Ring nitrogen in the additional hetero ring > Plural ring nitrogens in the additional hetero ring (e.g., imidazole, pyrazine, etc.) > Patents

Resources

Home

Browse by:

Browse by Category: Main > Health & Medicine

Class Information
Number: 514/235.8
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) > Morpholines (i.e., fully hydrogenated 1,4- oxazines) > Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding > Ring nitrogen in the additional hetero ring > Plural ring nitrogens in the additional hetero ring (e.g., imidazole, pyrazine, etc.)
Description: Subject matter in which the additional hetero ring contains plural ring nitrogens.

Sub-classes under this class:

Class Number	Class Name	Patents
514/236.5	The ring nitrogens are bonded directly to each other (e.g., pyridazine, etc.)	203
514/236.2	Three or more ring hetero atoms in the additional hetero ring	342

Patents under this class:

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Patent Number	Title Of Patent	Date Issued
5929077	Thioproline-containing inhibitors of farnesyl protein transferase	Jul. 27, 1999
5922706	Morpholine and thiomorpholine tachykinin receptor antagonists	Jul. 13, 1999
5916891	Pyrimidinyl imidazoles	Jun. 29, 1999
5914351	Anti-viral aromatic hydrazones	Jun. 22, 1999
5891877	Pharmaceutical compounds	Apr. 6, 1999
5883092	Pyrimidine derivatives as endothelin antagonists	Mar. 16, 1999
5872115	2-ureido-benzamide derivatives	Feb. 16, 1999
5869476	Pyrimidinone derivatives	Feb. 9, 1999
5869484	Phenylcarbamate derivatives suitable to the use as anticholinesterase substances	Feb. 9, 1999
5869481	Anticonvulsive 1-ar(alk)ylimidazolin-2-ones and process for making	Feb. 9, 1999
5866583	Substituted 2,4-diaminopyrimidines	Feb. 2, 1999
5866573	Pyrazinone thrombin inhibitors	Feb. 2, 1999
5866568	Heterocyclic compounds	Feb. 2, 1999
5861402	1,4-dihydropyridine compounds	Jan. 19, 1999
5859011	Dihydropyridine derivatives as bradykinin antagonist	Jan. 12, 1999
5852019	Pyrimidinylpyrazole derivatives	Dec. 22, 1998
5840721	Imidazole derivatives as MDR modulators	Nov. 24, 1998
5837708	Sulphonamides	Nov. 17, 1998
5834471	Amide derivatives as 5HT.sub.1D receptor antagonists	Nov. 10, 1998
5827847	Treatment of cognitive disorders with piperazine derivatives	Oct. 27, 1998
5817678	Inhibitors of farnesyl-protein transferase	Oct. 6, 1998
5786355	4,6-diarylpyrimidine derivatives and salts thereof	Jul. 28, 1998
5780467	Morpholine compounds are prodrugs useful as tachykinin receptor antagonists	Jul. 14, 1998
5763448	Pyrmidine derivatives	Jun. 9, 1998
5763445	Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith	Jun. 9, 1998
5756499	Substituted imidazole compounds	May. 26, 1998
5747486	Thienopyridine or thienopyrimidine derivatives and their use	May. 5, 1998
5747491	Morpholine derivatives and their use as antagonists of tachikinins	May. 5, 1998
5733907	Prodrugs of an inhibitor of HIV protease	Mar. 31, 1998
5731311	N,N-di(aryl) cyclic urea derivatives as anti-coagulants	Mar. 24, 1998
5731309	Substituted heteroalkyleneamine neurokinin antagonists	Mar. 24, 1998
5728708	Pharmacologically active pyridine derivatives and processes for the preparation thereof	Mar. 17, 1998
5728697	N,N-di(aryl) cyclic urea derivatives as anti-coagulants	Mar. 17, 1998
5726173	N.N-di (aryl) cyclic urea derivatives as anti-coagulants	Mar. 10, 1998
5723477	Modulators of acetylcholine receptors	Mar. 3, 1998
5719147	Morpholine and thiomorpholine tachykinin receptor antagonists	Feb. 17, 1998
5716955	Substituted imidazole compounds	Feb. 10, 1998
5712276	2-(n-alkylpiperazino or morpholino)-4-amino-5-aryl-pyrimidines	Jan. 27, 1998
5710149	Piperazine derivatives as 5-ht antagonists	Jan. 20, 1998
5703075	Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones	Dec. 30, 1997
5703071	Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases	Dec. 30, 1997
5700799	Oxazolidinone antimicrobials containing substituted diazine moieties	Dec. 23, 1997
5693674	Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis	Dec. 2, 1997
5693643	Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists	Dec. 2, 1997
5691336	Morpholine compounds are prodrugs useful as tachykinin receptor antagonists	Nov. 25, 1997
5691369	Cyclic ureas useful as antiarrhythmic and antifibrillatory agents	Nov. 25, 1997
5691335	Imidazolidine derivative and use thereof	Nov. 25, 1997
5691384	Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis	Nov. 25, 1997
5691356	Disubstituted heterocyclic thrombin inhibitors	Nov. 25, 1997
5688795	[3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy]-pyridine, pyrimidine and benzene derivatives as .alpha..sub.1 -adrenoceptor antagonists	Nov. 18, 1997